Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin Monotherapy
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The study hypothesis is that XOMA 052 improves glycemic control in subjects with Type 2
Diabetes.
Study X052078 is designed to establish efficacious dose(s) for future studies based on
improvement in HbA1c.